Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00633152 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections
A Phase 2 study of Bacterial Infection, sponsored by Forest Laboratories.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
- 13
- Study locations
NCT00633152: Completed Phase 2 study of Bacterial Infection, sponsored by Forest Laboratories.
NCT00633152 is a Phase 2 study of Bacterial Infection that has completed, run by Forest Laboratories. The registered enrollment target is 150 participants, above the 87-participant average among 8 other Bacterial Infection trials with a reported enrollment target (72% higher). The trial reports 13 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00633152, a Phase 2 study of Bacterial Infection, has completed, sponsored by Forest Laboratories.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
- 13
- Study locations
Study Summary
The purpose of this study is to determine whether ceftaroline is effective and safe in the treatment of complicated skin and skin structure infections in adults.
Primary Outcome
The coprimary efficacy outcome measures were the per-subject clinical cure rate at the Test of Cure (TOC) Visit in the Clinically Evaluable (CE) and (Modified-Intent-to-Treat) MITT Populations. Subjects were considered clinically cured at the Test of Cure (TOC) Visit if they had total resolution of all signs and symptoms of the baseline infection, or improvement of the infection to such an extent that no further antimicrobial therapy was necessary.
Conditions Studied
Interventions
- DRUG Aztreonam
- DRUG ceftaroline
- DRUG linezolid
Study Locations (13)
California
- Investigational Site - Buena Park
- Investigational Site - Long Beach
- Investigational Site - Los Angeles
- Investigational Site - Rolling Hills Estate
- Investigational Site - San Diego
Georgia
- Investigational Site - Columbus
- Investigational Site - Savannah
Ohio
- Investigational Site - Columbus
- Investigational Site - Toledo
Florida
- Investigational Site - Atlantis
Minnesota
- Investigational Site - Minneapolis
Montana
- Investigational Site - Butte
New Jersey
- Investigational Site - Somers Point
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-07 |
| Phase | Phase 2 |
What the finished NCT00633152 record still lists
NCT00633152 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 87-participant average among 8 other Bacterial Infection trials with a reported enrollment target (72% higher).
The record links to 1 condition, with Bacterial Infection appearing as the primary indexed condition, and to 3 interventions - of which Aztreonam is the first listed.
NCT00633152 lists 13 locations in 7 states (California, Georgia, Ohio).
Frequently Asked Questions
What is clinical trial NCT00633152 about?
NCT00633152 is a clinical study titled "Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections". The purpose of this study is to determine whether ceftaroline is effective and safe in the treatment of complicated skin and skin structure infections in adults.
What is the current status of trial NCT00633152?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2008-02. Estimated completion is 2008-07.
What conditions does trial NCT00633152 study?
This clinical trial studies the following conditions: Bacterial Infection.
What interventions are being tested in trial NCT00633152?
The interventions under investigation include: Aztreonam (DRUG), ceftaroline (DRUG), linezolid (DRUG).
Who is sponsoring clinical trial NCT00633152?
This trial is sponsored by Forest Laboratories, which has 145 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00633152 being conducted?
This trial has 13 study locations across California, Florida, Georgia, Minnesota, Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacterial Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00633152's enrollment target sits among peer trials
150 2nd of 8 higher than 6 of 8 other Bacterial Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bacterial Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
COMPLETED · Phase 2
-
Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites
COMPLETED · Phase 2
-
Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)
RECRUITING · Phase 4
-
Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea
RECRUITING · Phase 4
-
Larval Debridement Therapy Versus Sharp Debridement to Remove Biofilm
COMPLETED · NA
-
Safety of Intravenous Apramycin in Adults
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia